Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).
Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD, RECORD Study Group
Cardiovasc Diabetol 2008, 7:10
[Full text] [PubMed] [Related articles]
|
No citations for this article were found in PubMed Central.
|
